CFG
MEDP icon

Clayton Financial Group’s Medpace MEDP Stock Holding History

Clayton Financial Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27
Closed -$13.9K – 640
2025
Q3 		$13.9K Buy
+27
New +$11.8K 0.01% 126

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Clayton Financial Group's MEDP Position: Q4 2025 in Review

Clayton Financial Group sold out of Medpace (MEDP) in Q4 2025, closing a stake of 27 shares — an estimated $13.9K sold.

Clayton Financial Group first reported a position in MEDP in Q3 2025 and held it in 1 quarter. The position peaked at $13.9K in Q3 2025. 788 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Clayton Financial Group reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Clayton Financial Group sold 27 Medpace shares in Q4 2025, an estimated $13.9K.
  • Clayton Financial Group first reported a position in Medpace in Q3 2025 and held it in 1 quarter.
  • Clayton Financial Group's Medpace position peaked at $13.9K in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Clayton Financial Group's 13F filing for Q4 2025, filed 21 Jan 2026.